Back to top

Image: Bigstock

AxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session

Read MoreHide Full Article

AxoGen, Inc. (AXGN - Free Report) was a big mover last session, as the company saw its shares rise a little above 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Also, this led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 26% in the past one-month time frame.

The company has seen two negative estimate revisions in the past 30 days. Also, its Zacks Consensus Estimate moved lower over the same timeframe. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

AxoGen currently has a Zacks Rank #4(Sell), while its Earnings ESP is a negative.

AxoGen, Inc. Price

 

A top-ranked stock in the Medical – Generic Drugs industry is Corium International, Inc. sporting a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is AXGN going up? Or down? Predict to see what others think: Up or Down

Zacks' 2017 IPO Watch List

Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time.

One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


AxoGen, Inc. (AXGN) - free report >>

Published in